Answer:
The confluence of an increasing prevalence of end-stage renal disease (ESRD), clinical trial data suggestive of benefit from quotidian dialysis, and ongoing cost/benefit reanalysis of healthcare spending have stimulated interest in technological improvements in provision of ESRD care. For the last decade, our group has focused on enabling technologies that would permit a paradigm shift in dialysis care similar to that brought by implantable defibrillators to arrhythmia management. Two significant barriers to wearable or implantable dialysis persist: package size of the dialyzer and water requirements for preparation of dialysate. Decades of independent research into highly efficient membranes and cell-based bioreactors culminated in a team effort to develop an implantable version of the University of Michigan Renal Assist Device. In this review, the rationale for the design of the implantable artificial kidney is described.
Explanation:
Answer:
Neostigmine
Explanation:
This medication should be ideal to alleviate the muscle weakness since it is a drug that binds to and inactivates acetylcholinesterase.
In the case there is an acute myasthenic crisis where the patient has the inability to swallow and breathe properly it can not be administered orally, the parenteral form which is known as neostigmine methylsulfate should be used.
Child could be a late bloomer or have hearing problems, developmental problems or neurological problems
Answer:
Physical, Mental\ emotional, and Social health. Hopefully this helps!
